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RECENT technical advances in chromosome cytology have confirmed the exist-
ence ofa high degree ofconstancy in mammalian somatic tissues (Ford, Hamerton
and Mole, 1958; Tjio and Puck, 1958) and have served to throw into sharp relief
the diversity ofchromosome number that has been reported in malignant tumours
(Levan, 1956a; Ising and Levan, 1957; Manna, 1957 ; Klein, 1959; Makino,
Ishihara and Tonomura, 1959; Richards and Atkin, 1960). The association
of certain congenital abnormalities in man with loss or duplication ofsingle chro-
mosomes (Ford, Jones, Polani, de Almeida and Briggs, 1959; Jacobs and Strong,
1959; Lejeune, Gautier and Turpin, 1959) further demonstrates that profound
developmental disturbances may result from such changes. This could be inferred
from studies on lower animals and plants, but is only now susceptible of direct
investigation in man. On the other hand, though some mammalian tumours
have an apparently normal chromosome complement (Klein, 1959), the great
majority of those for which reliable counts are available present differences in
chromosome number from the normal, and from each other, which extend over a
wide range. Structural chromosomal changes, also, are common. Relatively
little is known however about human tumours as distinct from experimental
animal tumours. In the face of the great variation which appears to occur, it is
obvious that only by studying a large number of cases can any general pattern
be expected to emerge. Only then may it be possible to discover whether or not
a correlation exists between the chromosomal changes and the characteristics of
the tumour, such as its degree of autonomy, its tendency to invade or metasta-
size, its degree of differentiation, or tendency to metaplasia, or its sensitivity to
ionizing radiations.
Studies on "ascites" tumours of rodents indicate that each tumour strain
maintains, within limits, a degree of constancy, and has a modal chromosome
number which may not change for many transplant generations; however the
fact that changes may occur suggests that they may be a factor in the "pro-
gression" of tumours towards greater malignancy, or more specifically towards
adaptation to changing environmental conditions. Unfortunately, relatively
little is known about the chromosomes of primary (untransplanted) tumours,
even in experimental animals. Perhaps the most urgent and intriguing problem
is the relation of chromosomal change to the inception of the neoplastic process;
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especially in man, where the findings may have a direct relevance to the clinical
management of the condition.
Several complementary approaches are often necessary in the attack on any
single problem or group ofproblems: tissue-culture techniques, which have proved
so useful in the study of the chromosomes of normal cells (Tjio and Levan, 1956;
Tjio and Puck, 1958) and of marrow cells in leukaemias (Ford, Jacobs and Lajtha,
1958; Baikie, Brown, Jacobs and Milne, 1959), will no doubt be increasingly
applied to the study of malignant disease, and much may be learnt. Apart from
purely technical difficulties, however, the altered conditions in tissue-culture and
the possibility thereby of the selection of certain cell-types from a mixed popu-
lation may make it difficult to relate the findings to the state ofthe tumour before
its removal from the body. In a previous paper (Atkin and Richards, 1956), we
have discussed the application of microspectrophotometry to the study of human
tumours: from an estimate of the'amount of Feulgen stain, and hence of deoxy-
ribonucleic acid (DNA), in the individual cells of a tumour, data can be obtained
that give a measure of its chromosome complement. In a preliminary survey of
normal tissues and malignant tumours from various sites, we were able to demon-
strate that, while normal cells showed little variation from the diploid value, the
interphase cells in the tumour specimens tended to show a greater range of DNA
values, partly due to the presence of cells synthesizing DNA and partly to aneu-
ploidy and polyploidy. Nevertheless the majority of cells were grouped around a
modal value which varied in different tumours but in most cases was close to
either the diploid or tetraploid level. Since the near-diploid tumours frequently
had modes which were in fact a little above diploid, it was apparent that by this
criterion (i.e. the modal DNA value) the majority of tumours differed from the
normal. In a further study based on 14 cases in which we were able to compare
directly DNA content and chromosome number for the same tumour (Richards
and Atkin, 1960), it was found that the two sets of values were on the whole in
agreement, although in several cases the modal DNA content was higher than
would be expected if the ratio of DNA content to chromosome number which we
had previously found for normal tissues still held. The ratio of DNA to chromo-
some number exceeded the normal value on an average by 14 per cent, with a
range of -6 per cent to +47 per cent.
In this paper are reported the data obtained by microspectrophotometry of
Feulgen stain in a series of uterine carcinomata, which will be considered with
special reference to their clinical and histopathological features; in a parallel
paper (Richards and Atkin, 1959) the changes in DNA pattern that have been
observed in some of these tumours during and following radiotherapy (including
some radioresistant cases) are described.
MATERIALS AND METHODS
(a) Carcinoma of the cervix uteri.-Of 132 cases, biopsy material was obtained
before treatment from 124, while from the remaining 8 cases specimens of local
recurrences following radiotherapy only were measured. From 3 of the 124 cases
measurements were obtained both from the tumour before treatment and from
local recurrences which subsequently developed following radiotherapy. Thus the
total number of locally recurrent tumours that were measured is 11.
(b) Carcinomaofthe corpus uteri.-Measurements were obtained from 33 cases,
of which 30 had not previously received treatment.
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All the material was obtained under general anaesthesia in the operating
theatre; in the untreated cervix cases, biopsies were usually taken immediately
before the first Stockholm insertion. Part of the material was retained for cyto-
logical studies, including, in suitable cases, chromosome counts; from the
remainder, smears were prepared for subsequent measurement of Feulgen stain
as previously described (Atkin and Richards, 1956). At the same time, material
was sent for routine histological examination. Although there may be relatively
few late-stage cases, it is probable that the 124 cervix cases approximate to an
unselected series, since biopsies were performed at this hospital on almost every
case referred for treatment, including a number ofStage III and IV cases referred
for palliative radiotherapy. A few cases (under 5 per cent of the total number)
have been excluded from this series because of scarcity or absence of tumour cells
in the biopsy material.
In collating our results, derived as before from the measurement ofthe amount
of stain in a random sample of interphase cells, we have been concerned with (a)
the modal DNA value and (b) the variation within each sample. (a) The modal
DNA value.-In order to obtain a numerical value for the DNA mode, the follow-
ing procedure has been adopted: the average value in arbitrary units of cells
that fall within about 15 per cent of the mode is calculated: the data are plotted
in the form of a frequency histogram with classes having a spread of about ±5
per cent, and the 3 adjacent classes with the greatest number of cells are usually
averaged. This value is then adjusted to that ofthe mean ofthe leucocytes and/or
fibroblasts present in the specimen, which are given an arbitrary value of 100
units: this will be referred to as the basic DNA value. Since measurements on
normal epithelial tissues, including cervical epithelium and endometrium (Atkin
and Richards, 1956), have consistently been found to have modal DNA values
about 10 per cent greater than the mean value of the leucocytes and other cells
of mesothelial origin, it seems that the modal DNA value of epithelial tumours,
calculated as explained above, should be related to a normal diploid value of 110,
rather than to 100. (b) The variation in individual samples.-Histograms of the
DNA values ofa number ofindividual uterine tumours have been given elsewhere
(Atkin and Richards, 1956; Richaids and Atkin, 1959). In this paper we shall
confine ourselves to some general observations on the degree of spread of DNA
values in the tumour samples.
RESULTS
We will first consider the data derived from the tumour samples obtained
before treatment.
(a) The basic DNA values.-Excluding 2 cervical carcinomata, which are of
special interest and will be considered later, all the tumour samples presented a
clear mode. Fig. 1 shows the principal modal, or "basic ", DNA value, calculated
as described in the previous section, of 122 out of the 124 untreated cervical
tumours, and ofall the untreated corpus tumours. It will be seen that the cervical
tumours fall into 2 distinct groups. Taking the value 156 as the upper limit of
the lowergroup, there are 56 cases in the lowergroup and 66 in the upper. Further-
more, it can be seen that when the logarithm of the modal DNA value is plotted,
as in Fig. 1, each group presents an approximately normal distribution. The lower
group, which will be referred to as the " lowerploidygroup ", has a'rathernarrower
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distribution than the upper, with a coefficient of variation of 9 per cent, and a
mean of 121 i 11. It will be seen that this mean value is well above the mean
leucocyte (1) value of 100, and about 10 per cent above the value (110) which, as
already explained, we regard as the normal diploid epithelial value. There are in
fact only a few cases below 110. In contrast, the mean ofthe upper group (" upper
ploidy group ") is close to the normal tetraploid epithelial value (220), the range
is somewhat wider, and there are many hypotetraploid cases as well as some in
the hexaploid region (mean = 223 ± 43; coefficient of variation = 20 per cent).
Although the numbers are fewer, the corpus cases present differences from the
cervix caseswhichmaybesignificant: there arerelativelyfewertetraploidtumours
and none in the hypertetraploid-hexaploid region; on the other hand, there are
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FIa. 1.-Basic DNA value of 122 untreated cervical carcinomata (above), and 30 untreated corpus
carcinomata (below).
2hypodiploid tumours. The mean ofthe lower ploidy group ofthe corpus tumours
(neglecting the lowest value which is taken as being outside this range) is 118 i 13
(coefficient of variation 11 per cent).
The data are presented in tabular form in Table I. In order to obtain an esti-
mate ofthe number oftumours which fall close to the normal euploid levels, they
have been classified according to whether they fall within ±15 per cent of
the normal diploid epithelial value (110) or of twice this value. Seventy-two per
cent of the cervical tumours fall within one or other ofthese limits.
(b) The degree of spread of DNA values in individual tumours.-With a few
exceptions, this is not very great: in the majority of cases from 50-90 per cent
ofthe cells fall within i15per cent ofthe main mode. There is usually a secondary
mode at double the value ofthe main mode. The relative height ofthis secondary
mode varies in different tumours, reflecting the number of cells that have com-
pleted DNA synthesis prior to mitosis, or have achieved a doubling of the basic
chromosome complement by abnormal mitosis, endomitosis or endoreduplication.
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Taking the 2 principal modes together, we find that in most casss from 70 to 95
per cent of the cells fall within ±15 per cent of either of these limits. To obtain
a more precise estimate of the degree of spread, the results from the first 37 con-
secutive cervical cases were averaged, one case which had a wide spread being
excluded: 63 per cent of the cells fell within ±15 per cent of the main mode and
17 per cent within ±15 per cent of the secondary mode. In comparison, 2 speci-
mens ofnormal cervical epithelium and 2 ofnormal endometrium in the secretory
phase showed 91-96 per cent of the cells within these two limits: primary mode,
76-96 per cent; secondary mode, 0-17 per cent. The degree of spread in the
more undifferentiated tumours ofthe corpus uteri was similar to that in the cervix
tumours, but some of the well-differentiated corpus tumours showed less spread,
the values falling within the range for the normal tissues just quoted. In a few
tumours which had a main mode in the tetraploid region or above, there was a
smaller mode at about half the value of the main mode; the possible significance
of this finding will be discussed later. The cells that fell outside the two main
modal ranges only rarely had values much below diploid. In a few tumours, giant
cells (i.e. cells having values of from octoploid to 32-ploid or higher) were fairly
frequent.
It is necessary to consider to what extent variations in the DNA of the cells,
either as regards the position ofthe basic mode or the degree ofspread, may occur
in different regions of the same tumour, and therefore to what extent a small
sample oftissue is likely to be representative ofthe whole. Although some degree
ofvariation in any given case cannot be excluded, the rather limited observations
that have so far been made on samples from 2 or more regions ofthe same tumour
have revealed no significant differences, except in the relative prominence of the
primary and secondary modes.
Having described the variations in DNA content in a series of untreated
uterine tumours, we will try to assess the extent to which they can be related to
the histopathological and clinical features of the tumours.
TABLE I.-Untreated Cases Classified According to Basic DNA Value
Lower ploidy group = up to 156. Upper ploidygroup over 156. Diploid
group = 110 ± 15percent (94-126). Tetraploidgroup 220 ± 15percent
(187-233).
Carcinoma Carcinoma
of cervix of corpus
FHypodiploid . 0 2
Lower ploidy group Diploid . 44 19
Hyperdiploid . 12 . 3
56 . 24
'Hypotetraploid . 10 1
Upper ploidy group Tetraploid . 45 5
LHypertetraploid 11 0
66 . 6
Wide range (diploid-tetraploid) 2 . -
124 . 30
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Histopathology
In Table II, the histological type ofthe tumours, classified as before according
to the value of the basic DNA mode, is shown. It will be seen that there is no
correlation between the DNA level and the degree of differentiation of the squa-
mous cell carcinomata of the cervix, but that all the well-differentiated tumours
of the corpus are diploid or hypodiploid. None of the adenocarcinomata or
adenoacanthomata of the cervix,. however, falls into the diploid or hypodiploid
class. Thus there appears to be a significant difference between the squamous
cell carcinomata of the cervix, which are frequently near-diploid, and the adeno-
carcinomata and adenoacanthomata, none of which has a near-diploid mode,
although 2 of the adenoacanthomata have a wide range of values, including some
in the diploid region. Table II shows that there are 45 squamous cell tumours in
the diploid group and 70 in the higher-than-diploid groups, whereas the 17 tumours
of the other two histological types are all above diploid or have no clear mode.
This difference is highly significant (p - 0.00054); the limits that we have taken
for the "diploid" group are purely arbitrary, but if we narrow the diploid group
to 10 per cent or broaden it to ±20 per cent, the differences are still significant
(p _ 0.0020 and 0.012 respectively). The adenoacanthomata of the corpus uteri,
unlike those ofthe cervix, are all in the diploid class.
There does not appear to be any correlation between the gross pathological
type of the cervical tumours and the basic DNA value. Thus predominantly
exophytic tumours occured in both the diploid and tetraploid classes.
Clinical Features
(A) Carcinoma of the cervix
(i) Age ofpatient.-The age-distribution of the lower and upper ploidy groups
are compared in Fig. 2. There are relatively more younger and older patients, as
compared with those in the middle age-groups, in the upper ploidy group, espe-
TABLE III.-Carcinoma of the Cervix: Age of Patient, at Time of First Treatment,
Compared with the Basic DNA Value
Under Over
45 years 45-64 years 64 years
Dpod . . 9 . 28 . 7 Lower ploidy group Hyperdiploid . 9 . 28 . 7
Hyperdiploid 2 6 . 4
rHypotetraploid . 4 . 5 . 1
Upper ploidy group Tetraploid . . 15 . 12 18
Hypertetraploid . 4 . 4 . 3
Wide range (diploid-tetraploid) . . 0 . 2 . 0
34 . 57 . 33
cially above the age of 74 where there are 11 cases as compared with 1 in the lower
group. From Table III, it can be seen that there is a preponderance of cases in
the middle age-groups (45-64 years) in the diploid class, but relatively fewer
patients in these age-groups in the tetraploid class. These differences are not
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statistically significant, however, and would have to be confirmed by observations
on further cases.
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FIG. 2.-Age-distribution of 122 untreated cervical tumours. ABOVE:
BELOW: upper ploidy group.
lower ploidy group.
(ii) Clinical stage.-There appears to be no correlation between the clinical
stage and the basic DNA value (Table IV).
TABLE IV.-Clinical Stage of Cervical Carcinomata
C-
I
. 14 Lower ploidy group Hyperdiploid . 2 Hyperdiploid . 2
16
rHypotetraploid . 1
Upper ploidy group Tetraploid . . 19
LHypertetraploid . 3
23
Wide range . .
Clinical stage
-A_
II III IV
15 10 5
5 4 1
20 14 6
Total
. 44
. 12
. 56
2 5 2 . 10
12 8 6 . 45
5 3 - . 11
19 16 8 . 66
2 - . 2
124
(iii) Response to treatment.-The great majority of cases were treated by a
radical course of radiotherapy: either 3 radium insertions (modified Stockholm
technique) or a single radium insertion supplemented by external irradiation with
the 4 MeV linear accelerator. A few cases, mostly advanced, received external
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irradiation with the linear accelerator or telecobalt unit only. The average
duration of follow-up, excluding 32 cases that have died, is 14.6 months, with a
range of 0-52 months. Ofthe 32 cases that have died, 11 were in the diploid class
and 12 in the tetraploid. Thus there appears to be no correlation between the
DNA value and the survival rate, although most cases have only been followed
up for a short time. If however we consider those cases that developed a local
recurrence in the cervix or vault of vagina, or were found to have viable tumour
tissue in the cervix at subsequent operation, performed at least 21 months after
the first treatment, we find that only one out of 11 had a diploid mode (Fig. 3).
Squamous cell
Adenocarcinoma
Adenoacanthoma
CD
U,
C.) 0
o
Z
DNA(logscale)
FIG. 3.-Carcinoma of the cervix: radioresistant tumours. The basic DNA value of the un-
treated tumours which subsequently recurred locally after radiotherapy is shown (shaded)
above the baseline; also, below the baseline are indicated the measurements made on local
recurrences. The continuous outline indicates the values obtained for all the untreated
tumours.
It was possible to obtain measurements on the local recurrences of 3 of these
tumours, and of 8 further cases from which pre-treatment biopsies were not
available. The DNA values of these local recurrences are indicated below the
base-line in Fig. 3. When the data from these cases which showed a poor local
response to radiotherapy are compared with the distribution of DNA values of
all the untreated tumours (indicated by the continuous line in Fig. 3), it can be
seen that the former are more evenly distributed through the ploidy ranges, the
majority being significantly greater than diploid. The 2 adenoacanthomata that
showed a wide spread of values before treatment (not indicated in Fig. 3) gave
rise to local recurrences both of which had modes in the triploid region: histo-
grams of these cases, including those derived from specimens obtained during
the course of radiotherapy, are illustrated in the parallel paper (Richards and
Atkin, 1959). Brief details of the cases that recurred locally are given below.
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Case
No.
32
46
72
Age-Stage-Degree of differen-
tiation (histology: squamous
cell carc. unless otherwise
stated)-treatment (St. =
Stockholm radium insertion)
50 - IV - Poor (adenoacanth-
oma). 1 St. + DXR
40 - I - Poor (adenoacanth-.
oma). 3 St. + DXR
59 - II - Poor (adenoacanth-.
oma). 3 St. + DXR
78 . 52-lI-Good. 3 St.+DXR .
105 . 72 - IV - Poor (adenocarci- .
noma of cervical stump).
Intracav. Ra + DXR
115 . 58-III-Poor. Intracav. Ra .
(ovoids) + DXR
319 . 51 - II - Poor. 3 St.
427 . 45 - ? - Good (adenocarci- .
noma). Total hysterec-
tomy followed by DXR to
whole pelvis (4000 r)
480 . 40 - II - Poor. 3 St.
502 . 66 - II - Poor (adenoacanth-.
oma). 3 St.
537 . 47 - II - Poor (adenoacanth-
oma). 3 St.
548 . 39 - I - Poor. 3 St.
584 . 43 - I -Poor. 3 St.
585 . 61 - III - Poor. Telecobalt .
(7000 r)
703 . 45 - I - Poor (areas of mod.
diffn.). 3 St.
756 . 73-II -Moderate. 1 St. +-
radical DXR to pelvis
824 . 53 - II - Poor. 4 MeV linear
accelerator
825 . 32 - III - Poor. 4 MeV linear
accelerator
833 . 60 - III - Poor. 4 MeV lin- .
ear accelerator
(B) Carcinoma of the corpus
Basic DNA
value
before
treatment
197
Subsequent history
(figures indicate time in
months after first
treatment)
. No response. 3: died
- .8 : local recurrence. Further
DXR (no response)
Wide range . Tumour failed to regress. 2:
laparotomy. Died shortly
afterwards
- . 2 : local recurrence. Wert-
heim's hysterectomy (died
post-operatively)
211 10: died; primary tumour still
present
157 . 3 : local recurrence; Wert-
heim's hysterect. 27: symp-
tom-free
- . 7 : local recurrence; DXR.
Died shortly after
- . 7: tumour present in vault of
vagina; further DXR. Sub-
sequently died (tumour still
present in vault)
133 8: cervix very hard (clinically
recurrent growth, but biopsy
negative) ; external irradia-
tion (4 MeV linear accel.).
15: deteriorating
347 . 10: local recurrence; Raneedle
implant-recurrence disap-
peared. 16: mass in pelvis
Wide range . Failed to regress. 24: positive
biopsy; DXR. 8; died
5 : local recurrence ; Wert-
heim's hysterect. 13: recur-
rent nodule in vagina; treat-
ment by 4 MeV linear accel.
217 4 : local recurrence ; Wert-
heim's hysterect. 10: vault
recurrence and secondaries
in scar; palliative DXR. 12:
deteriorating
117 . 6 : mass side wall of pelvis--
but cervix healed. 10: local
recurrence
228 . 4: cervix still bulky ; Wert-
heim's hysterect. (tumour
cells present in cervix)
130 . 3: tumour still present in post- -
fornix
10: recurrence in cervix
. 5: recurrenca in cervix
. 30: recurrence in cervix
The age-distribution of the DNA classes for the 30 untreated cases is given in
Table V. Sixteen of these cases were treated by an intracavitary Co60 source
(Strickland, 1953), and their subsequent history is given in Table VI. Owing to
Basic DNA
value of
local
recurrence
344
161
200
139
127
242
168
107
208
148
277
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TABLE V.-Age-distribution of Untreated Cases of Carcinoma of the Corpus Uteri
Age
45-49 50-54 55-59 60-64 65-69 70-74 75-79
rHypodiploid . 1 --
Lower ploidy group Diploid . . 2 4 4 4 3 1 1
LHyperdiploid .1 - - 1 1 -
Hypotetraploid . 1 Upper ploidy group tetraploid 1 2 2 Tetraploid
. . 1 2 2
TABLE VI.-Response to Treatment of 16 Cases of Carcinoma of the Corpus Uteri
Treated by Intracavitary Co60 Source
Subsequent
Wertheim's
hysterectomy No evidence of
(1-3 months later) recurrence (no Subse-
-no tumour found operation performed). quent
on microscopic Followed up for recurrence Not
examination at least 2 years in pelvis known
fHypodiploid . 2 . -- . . Lower ploidy group HypoDiploid . 2 . 4 3 1 3
fHypotetraploid . -- . . 1 .- Upper ploidy group ypotetraploid. - .Tetraploid 2.
the small number of cases, no deductions can be drawn from these figures, other
than that both diploid and tetraploid cases may show a satisfactory response to
this mode of treatment.
Details of the 3 cases which had received previous treatment are given below.
Case No. 127.-Total hysterectomy in 1947, when aged 71, for moderately well-
differentiated columnar cell adenocarcinoma. Eight years later, polypoid mass in
vault ofvagina (histological appearance asbefore), treated byintracavitary radium
with good response. Basic DNA value 239.
Case No. 141.-Total hysterectomy followed by DXR topelvisin 1953; adeno-
acanthoma of moderate differentiation, aged 56. Two years later: vault
recurrence (similar histology); treated by intracavitary radium followed by total
vaginectomy. Died 6 months later: secondaries in the abdomen; no tumour
found in the pelvis at post mortem. Basic DNA value 122.
Case No. 468.-Treated for carcinoma ofthe endocervix in 1954 by Stockholm
radium technique: moderately well differentiated columnar cell adenocarcinoma;
then aged 76. In 1957, treated by total hysterectomy for ? recurrence ? new
primary in body of uterus: columnar cell adenocarcinoma, largely anaplastic,
with a few areas of moderate differentiation-basic DNA value 225.
DISCUSSION
The distribution of the basic DNA values of the cervical carcinomata (Fig. 1)
strongly suggests the presence of two distinct populations; it is reasonable to
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chromosome complement at some stage of their evolution. The central tendency
in both groups is clear, and indicates that there is an optimal region, deviations
from which are progressively less likely to occur in proportion to their magnitude.
The significance of the fact that the majority of tumours in the lower group are
hyperdiploid rather than diploid as regards DNA content is not clear. Data on
stem-line chromosome counts collected by Ising and Levan (1957) suggest that
human tumours in general are quite frequently hyperdiploid, and less often
hypodiploid. This is supported by our own somewhat limited observations on the
chromosome numbers of the uterine tumours in the present series, counts in the
range 48-52 being commonly found (unpublished data). On the other hand,
Manna (1957) has found that many human cervical tumours have chromosome
modes in the hypodiploid region. It is concluded that more critical chromosome
counts are necessary before we can assess the extent to which tumours with near-
diploid basic DNA values do in fact differ from the normal in their chromosome
complement. If our finding (Richards and Atkin, 1960) of an average of 14 per
cent more DNA per chromosome in tumours than in normal tissues were true of
cervical tumours in general, we should expect the distribution of modal chromo-
some numbers ofthe near-diploid tumours to show a peak very close to the diploid
number, and not in the hyperdiploid region. However, our data, based on a small
series of cases in which it was possible to compare DNA content with chromosome
number for the same tumour, probably do not justify such a conclusion; indeed
they suggest that the discrepancy between DNA content and chromosome number
is on the whole greater for the tumours with higher chromosome numbers, and
minimal for the near-diploid group.
The tumours in the upper group show a distribution that is centred on a value
less than twice that of the lower group, and moreover have a rather wider range
extending from the triploid to the hexaploid or hypo-octoploid region. Does this
represent a similarly wide range of chromosome numbers ? Bader (1959), in the
course of microspectrophotometric measurements of DNA in a small series of
human ovarian carcinomata, found in one case a discrepancy between the cells
in anaphase, which fell into the diploid range, and those in interphase, which had
a mode in the tetraploid region, and has suggested that tumours which are
"tetraploid" as regards DNA content may not necessarily have a near-tetraploid
chromosomenumber, since" a combinationofdiploid cellshavingdoubledamounts
of DNA and tetraploid cells having the tetraploid amount of DNA would result
in a distortion of an interphase frequency distribution relative to the anaphase
frequency distribution ". We have already pointed out that some ofour tumours,
which have their main mode in the tetraploid or hypertetraploid region, have in
addition a smaller mode in the diploid-hyperdiploid region. Cytological studies
on aceto-orcein squash preparations (Atkin and Ross, unpublished) indicate that
these particular tumours are usually characterized by a high incidence of endo-
mitosis, as also may be those that have a basically hyperdiploid mode plus a
prominent hypertetraploid secondary mode; furthermore, although the chromo-
somes in these tumours are frequently crowded, sufficiently accurate counts have
been possible to indicate that cells with near-diploid and near-tetraploid chromo-
some complements can reach an apparently normal metaphase stage. It is not
known, however, whether the tetraploid cells can complete mitosis. It may be,
therefore, that the DNA mode is not representative of the chromosome number
of the stem-line in all cases; indeed, if there are two classes of dividing cells, one
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having twice the chromosome complement of the other, it seems quite likely that
their relative frequencies cannot be deduced from the relative heights of the
corresponding DNA modes. However, the tumours which have a lower secondary
mode are in the minority (about 25-30 per cent of those tumours whose basic
DNA value lies between 220 and 260), and for most tumours which are
" tetra-
ploid" as regards DNA content, the photometric findings are consistenit with the
cytological observations: chromosome counts, average nuclear size, and, where
sex chromatin is evident, the presence of 2 sex chromatin bodies per nucleus
(Atkin, 1960).
The occurrence of endomitosis in the hyperdiploid-hypertetraploid group of
tumours, which includes those hypertetraploid tumours which do not have a
hyperdiploid secondary mode, suggests that these tumours may be in the process
of, or may have completed, a transition from the lower to the higher ploidy. Whether cells with a doubled chromosome complement can take over as a new
stem-line will of course depend on whether they are capable of normal mitosis.
The greatest significance of polyploidy, however, may be that it forms the basis
for further evolution. Levan (1956b) has pointed out that "tetraploidy in mouse
tumours is often only a transient stage on the way to hypotetraploidy. . .
secondary numerical variation is often superimposed on the chromosomal
doubling". Although this may well be true for human tumours also, there is no
direct evidence for this at the moment. The uterine tumours with hypotetraploid
DNA modes do not show much endomitosis, nor do they have lower secondary
modes; their mode of evolution is at present unknown.
In view of the above considerations, it is not surprising that no clear-cut
correlation appears between the clinical and histopathological features of the
tumours and their DNA values. It might be that those tumours which deviate
markedly from the diploid or tetraploid levels (i.e. those in the triploid or hexa-
ploid region) could be regarded as genetically "unbalanced" and be expected
more often to show anomalous behaviour. However, we encounter the difficulty
that their numbers are fewer, and that they form a continuous series merging
into the morenearly "euploid" tumours, so that any classification for statistical
purposes must be purely arbitrary.
The perhaps significantly higher incidence in the cervical tumours of high
basic DNA values at the extremes of the age-range may reflect a greater tendency
towards polyploidization, perhaps due tohormonal stimuli, in the younger and
older patients as compared with those in the middle age-groups. It is clear that
there is no correlation in the squamous cell cervical tumours between the degree
of differentiation and ploidy level. This lack of correlation has also appeared in
data (unpublished) on squamous cell tumours from other sites, including vulva,
larynx and tongue, where well-differentiated tumours are relatively commoner.
On the other hand the figures for the corpus tumours suggest that here there may
be a correlation between degree of differentiation and ploidy, since all the well-
differentiated tumours are either diploid or hypodiploid; it may be that the
degree of correlation between ploidy and differentiation varies in tumours of
different histological type. Perhaps therefore the finding that the adenocarcino-
mata of the cervix have predominantly high basic DNA values, in the small series
ofcases that we have observed, may be related to their more or less undifferentiated
character rather then to any other factor.
The adenoacanthomata of the cervix require further consideration. Nn.e of
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these had a diploid DNA mode, although before treatment two of them had a
heterogeneous population (as regards DNA values) which included a number of
cells in the diploid region. After irradiation therapy, however, in both these cases
there emerged an actively-growing strain of cells having a triploid DNA mode.
A further case, from which a pre-treatment specimen was not obtained, gave rise
to a local recurrence which proved to have a main mode in the hexaploid region,
with a smaller triploid mode. The rather frequent occurrence oftriploid/hexaploid
DNA modes in those adenoacanthomata which proved markedly radioresistent
appears to be of particular interest. The possibility of a link between the histo-
genesis of these tumours, which has been discussed by Gluiicksmann and Cherry
(1956) who also find that they frequently respond poorly to radiotherapy, their
apparently anomalous DNA content and often radioresistant character would
appear to merit further investigation.*
The data from the squamous cell carcinomata of the cervix that subsequently
recurred locally and the measurements actually made on local recurrences (Fig. 3)
indicate that these tumours are often higher than diploid, although the difference
in distribution from that of the tumours which responded satisfactorily is not
statistically significant. It is clear that there is no simple correlation between
radiosensitivity and basic DNA level. Perhaps however with an increase in
chromosome number there is the increased possibility ofvariation, which in some
tumours may lie in the direction ofgreater radioresistance.
SUMMARY
1. The DNA content oftumour cells from 132 cases ofcarcinoma ofthe cervix
and 33 cases of carcinoma of the corpus has been estimated by microspectro-
photometry.
2. In all except 2 of the cervical tumours, a clear mode was apparent in the
frequency distribution of DNA values of a random sample of interphase cells:
in most tumours, from 50 to 90 per cent of the cells fell within ±15 per cent of a
modal value, which has been referred to as the basic DNA value.
3. The basic DNA values of individual tumours were found to extend over a
wide range, but fell into 2 main groups centred on the hyperdiploid and tetraploid
levels respectively. This distinction into 2 groups was clearly seen in the cervical
tumours although individual tumours ranged from diploid almost to the octoploid
level. There were relatively fewer corpus tumours in the tetraploid region and
none with DNA values above tetraploid; on the other hand there were 2 hypo-
diploid tumours.
4. The relation of the basic DNA value to the chromosome number of the
tumour cells is discussed, and it is concluded that in the majority of cases the
DNA value bears a reasonably close quantitative relationship to the modal
chromosome number, although from evidence obtained in a previous study a
strict parallelism is not necessarily to be expected. There is evidence that some
of the cervical tumours may be in the process of transition from a hyperdiploid
to a hypertetraploid DNA value by means of endomitosis or some other chromo-
somal-doubling process.
* Measurements have recently been obtained on 3 further adenoacanthomata of the cervix.
Two had basic DNA values of 131 and 153 respectively before treatment. A specimen from the third
case was not obtained before treatment, but one taken 7 days after the first Stockholm insertion
had DNA modes in the triploid and hexaploid regions.
786DNA CONTENT OF CARCINOMA OF UTERUS 787
5. There is no significant relation in the cervical tumours between basic DNA
value and clinical stage or age of the patient, although there is a suggestion that
tetraploid tumours may be relatively commoner at the extremes ofthe age-range.
6. There does not appear to be a correlation between the degree of differen-
tiation of the squamous cell cervical tumours and their basic DNA value. All of
the 7 well-differentiated corpus tumours however are eitherdiploid orhypodiploid,
but the numnber of cases is not large enough to demonstrate a statistically signi-
ficant correlation. There is a significant difference between the squamous cell
tumours ofthe cervix, whicharefrequentlynear-diploid, andtheadenocarcinomata
and adenoacanthomata of the cervix, none of which has a near-diploid mode.
7. Data derived from (i) untreated cervical tumours which subsequently
recurred locally and (ii) measurements made on local recurrences suggest that
radioresistant cell strains are more often higher-than-diploid than near-diploid.
In particular, several adenoacanthomata which responded poorly to radiotherapy
had tetraploid, triploid or hexaploid modes, the two latter being relatively un-
common among the squamous cell tumours.
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